SYNLAB UK & Ireland:
SYNLAB sets its Sights on Becoming the UK’s Leading Laboratory Diagnostics Organisation
Science for Life, Health and Wellbeing SYNLAB, the medical diagnostics provider, has set out its ambition to become the UK’s leading laboratory diagnostics organisation by…
Modern Slavery & Human Trafficking Statement 2023
INTRODUCTION This is SYNLAB UK and Ireland’s (SYNLAB UK&I) Modern Slavery and Human Trafficking Statement under Section 54 of the UK Modern Slavery Act 2015…
Exceptional talent honoured during SYNLAB awards programme
SYNLAB’s 2022 Excellence Awards recognised individuals and teams from across its UK & Ireland services, who display outstanding service in their roles. The awards ceremony…
SYNLAB Primed to Help Steer NHS’s COVID Bounce Back
SYNLAB is ready to play a key role in assisting the UK’s ongoing COVID recovery after securing membership of NHS England’s Increasing Capacity Framework (ICF)….
Landmark Day for Pathology Partnership with Launch of Synnovis Brand
A pathology partnership performing 32 million tests a year has been relaunched as ‘Synnovis’ – officially heralding the start of a new era for clinicians…
Pathology laboratory becomes the first in the UK to support remote plate reading
A pathology laboratory is leading the way in speeding up access to patient care and treatment after becoming the first in the UK to enable…
SYNLAB ESG Roadmap and Framework
Introduction SYNLAB UK&I is thrilled to publish its UK&I ESG Framework and Roadmap, which outlines out how we will achieve our ESG Goals. In it…
GENDER Pay Gap Report 2020-21
A Message From Our CEO Whilst we are pleased at the improvement in our gender pay gap over the past four years, we know that…
SYNLAB Goes Public
We are proud to announce that SYNLAB is now listed on the Frankfurt Stock Exchange. This historical milestone is built on the dedication and passion…
